^
Association details:
Biomarker:No biomarker
Cancer:Hodgkin Lymphoma
Regimen:ABVE-PC
Direction:Sensitive
Evidence:
Evidence Level:
Sensitive: A2 - Guideline
Source:
Published date:
01/12/2023
Excerpt:
Pediatric Hodgkin Lymphoma....Additional Treatment….ABVE-PC, Inadequate response (SRL), ABVE-PC x 3 cycles